Dergiler / Solunum / 2015 / Cilt: 17 - Sayı: 1

Comparison of Severity Scoring Systems in Community-Acquired Pneumonia

Dergi
Solunum
Sayfa
15–21
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The three systems accurately detected the need for IRVS and the 30-day mortality, but none individually demonstrated any advantage over the others

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The aim of this study was to compare the ability of CURB-65, pneumonia severity index and SMART-COP systems to predict 30-day mortality and the need for intensive respiratory and vasopressor support (IVRS).Methods: We included 84 cases with community acquired pneumonia (CAP) and followed up for 30 days.
📊
Temel Bulgular & Veri:The scores were calculated at admission and associated with the 30-day mortality and the need for intensive respiratory and vasopressor support.Results: The mean age of patients was 58.6±18.7 years.
💡
Sonuç & Katkı:Conclusion: The three systems accurately detected the need for IRVS and the 30-day mortality, but none individually demonstrated any advantage over the others
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

The aim of this study was to compare the ability of CURB-65, pneumonia severity index and SMART-COP systems to predict 30-day mortality and the need for intensive respiratory and vasopressor support (IVRS).Methods: We included 84 cases with community acquired pneumonia (CAP) and followed up for 30 days. The scores were calculated at admission and associated with the 30-day mortality and the need for intensive respiratory and vasopressor support.Results: The mean age of patients was 58.6±18.7 years. The 30-day mortality level for CAP was 7.1%. Fourteen of 84 patients (16.7%) with CAP were followed in ICU. The area under curve (AUC) values of the three systems (CURB-65, PSI, and SMART-COP) for 30-day mortality were 0.89, 0.89 and 0.91, respectively, and for the need for IRVS was 0.88, 0.91 and 0.93, respectively. Conclusion: The three systems accurately detected the need for IRVS and the 30-day mortality, but none individually demonstrated any advantage over the others

🔖

Bu Makaleye Atıf Yap

ALICI, İ. O., ÇAPAN, N., ERTÜRK, A., CANBAKAN, S. (2015). Comparison of Severity Scoring Systems in Community-Acquired Pneumonia. Solunum, Cilt: 17 - Sayı: 1, 15–21. https://ajindex.com/articles/314287

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. T.C. Sağlık Bakanlığı, Refik Saydam Hıfzıssıhha Merkezi Başkanlığı Hıfzıssıhha Mektebi Müdürlüğü, Başkent Üniversitesi Ulusal Hastalık Yükü ve Maliyeti Etkinlik Projesi, 2004 (www.toraks.org.tr). Acute respiratory infections in under-fives: 15 million deaths a year. Lan- cet 1985; 2: 699-701. Centers for Disease Control and Prevention (CDC). Introduction to Table V. Premature deaths, monthly mortality and monthly physician contacts: United States. MMWR Morb Mortal Wkly Rep 1997; 46: 556-61.
  2. Pio A, Leowski J, Luelmo F. Epidemiological magnitude of the problem of acute respiratory infections in children in developing countries. Bull IUAT 1983; 58: 199-204.
  3. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, et al. Trends in infectious diseases mortality in the United States. JAMA 1996; 275: 189-93. [CrossRef] Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitaliza- tion. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997; 157: 1709-18. [CrossRef] Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the the National Health Service in the UK. Eur Respir J 1997; 10: 1530-4. [CrossRef] Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820-37. [CrossRef] Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, et al. The burden of community acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 2004; 39: 1642-50. [CrossRef] Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiol- ogy of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15: 757-63. [CrossRef] Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community acquired pneumonia. N Engl J Med 1997; 336: 243-50. [CrossRef] Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82. [CrossRef] Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, et al. SMART- COP: a tool for predicting the need for intensive respiratoy or vasopres- sor support in community-acquired pneumonia. Clin Infect Dis 20